Trial results show no survival benefit with the use of proton… | HappeningNow.news

Health · 42 views

Trial results show no survival benefit with the use of proton therapy in patients with advanced hepatocellular carcinoma

Initial results of the NRG Oncology NRG-GI003 clinical study comparing proton and photon therapy for patients with advanced hepatocellular carcinoma (HCC) indicate that proton therapy did not improve the primary objective of overall…

Source Summary Published October 5, 2026 Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 42 Community interest
Brief read Under 1 min brief 90 words

Summary

Initial results of the NRG Oncology NRG-GI003 clinical study comparing proton and photon therapy for patients with advanced hepatocellular carcinoma (HCC) indicate that proton therapy did not improve the primary objective of overall survival (OS). At the planned interim analysis, the trial was released for reporting after it crossed the futility boundary. Proton therapy also did not improve the trial's secondary endpoints, including progression-free survival (PFS) and local progression (LP). Although fewer grade 3 or higher treatment-related adverse events were observed with proton therapy than with photon therapy (11% vs.

Read original at Medical Xpress

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page